echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Feed Industry News > Vaccination has nothing to do with human BSE

    Vaccination has nothing to do with human BSE

    • Last Update: 2001-12-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Lead: Reuters news UK scientists ruled out human infection with mad cow disease after vaccinating two volunteers in the same batch on Monday Peter Smith, chairman of BSE Research Council in the UK, said the Council had always held that human BSE infection was not related to vaccination The two volunteers were vaccinated with the same batch of vaccine in order to further study the possibility of bovine serum products infecting humans The scientists concluded that vaccines made from British bovine blood products are no more likely to infect Creutzfeldt Jakob disease than those made from other countries' bovine blood products (author:) share to feed Weibo share to:
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.